Skip to main content
Journal cover image

Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia.

Publication ,  Journal Article
Hinds, PS; Hockenberry, MJ; Gattuso, JS; Srivastava, DK; Tong, X; Jones, H; West, N; McCarthy, KS; Sadeh, A; Ash, M; Fernandez, C; Pui, C-H
Published in: Cancer
November 2007

Dexamethasone improves the cure rate of childhood acute lymphoblastic leukemia (ALL) but causes physical and behavioral adverse events. The objective of the current study was to determine the effect of dexamethasone exposure on sleep and fatigue in pediatric patients with ALL.One hundred pediatric patients with low-risk or standard-risk ALL were enrolled on 1 of 3 protocols (St. Jude Total XV, Children's Oncology Group [COG] 9904, or COG 9905) at 3 institutions. The mean age of the cohort was 9.24 +/- 3.23 years (range, 5.03-18.14 years). The majority of patients were white (79%) males (62%) with standard-risk ALL (63%). The cohort was divided into 4 subgroups: St. Jude low-risk, St. Jude standard-risk, COG low-risk, and COG standard-risk. Patients wore a wrist actigraph to monitor sleep activity during 2 consecutive 5-day periods: During the first period, they did not receive dexamethasone; and, during the second period, they did. Patients and their parents completed fatigue instruments on Days 2 and 5 of each period, and parents completed sleep diaries.Actual sleep minutes, sleep duration, total daily nap minutes, and fatigue increased significantly during the dexamethasone treatment for 3 to 4 of the subgroups. Total daily nap minutes increased significantly for both standard-risk groups during the dexamethasone treatment. Parents reported significant increases in their child's nighttime awakenings, restless sleep, and nap time during dexamethasone treatment.Dexamethasone treatment during continuation therapy for childhood ALL significantly and adversely altered sleep and fatigue, confirming that sleep and fatigue are behavioral responses to dexamethasone.

Duke Scholars

Published In

Cancer

DOI

EISSN

1097-0142

ISSN

0008-543X

Publication Date

November 2007

Volume

110

Issue

10

Start / End Page

2321 / 2330

Related Subject Headings

  • Sleep
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Oncology & Carcinogenesis
  • Male
  • Humans
  • Female
  • Fatigue
  • Dexamethasone
  • Child, Preschool
  • Child
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hinds, P. S., Hockenberry, M. J., Gattuso, J. S., Srivastava, D. K., Tong, X., Jones, H., … Pui, C.-H. (2007). Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. Cancer, 110(10), 2321–2330. https://doi.org/10.1002/cncr.23039
Hinds, Pamela S., Marilyn J. Hockenberry, Jami S. Gattuso, Deo Kumar Srivastava, Xin Tong, Heather Jones, Nancy West, et al. “Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia.Cancer 110, no. 10 (November 2007): 2321–30. https://doi.org/10.1002/cncr.23039.
Hinds PS, Hockenberry MJ, Gattuso JS, Srivastava DK, Tong X, Jones H, et al. Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. Cancer. 2007 Nov;110(10):2321–30.
Hinds, Pamela S., et al. “Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia.Cancer, vol. 110, no. 10, Nov. 2007, pp. 2321–30. Epmc, doi:10.1002/cncr.23039.
Hinds PS, Hockenberry MJ, Gattuso JS, Srivastava DK, Tong X, Jones H, West N, McCarthy KS, Sadeh A, Ash M, Fernandez C, Pui C-H. Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. Cancer. 2007 Nov;110(10):2321–2330.
Journal cover image

Published In

Cancer

DOI

EISSN

1097-0142

ISSN

0008-543X

Publication Date

November 2007

Volume

110

Issue

10

Start / End Page

2321 / 2330

Related Subject Headings

  • Sleep
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Oncology & Carcinogenesis
  • Male
  • Humans
  • Female
  • Fatigue
  • Dexamethasone
  • Child, Preschool
  • Child